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1. Introduction 
Diabetes mellitus is a metabolic disorder characterized by increased blood glucose levels with instability in 
carbohydrates, fat and protein metabolism. It is a most serious and chronic disease whose incidence rates are increasing 
obesity and also with aging of the general population of the world. Currently, an estimated 150 million people worldwide 
have diabetes and that this will increase 220 million by 2010 and 300 million by 2025[1]. Globally, type II diabetes (Non 
insulin dependent diabetes mellitus) accounts for greater than 90% of the cases [2]. An increased level of glucose in the 
blood can damage some of the body’s systems, such as the blood vessels and the nerves [3]. One therapeutic approach to 
decrease postprandial hyperglycemia is to retard absorption of glucose via inhibition of carbohydrates hydrolyzing 
enzymes, such as α-glucosidase and α- amylase.  
Evaluation and identification of some new natural molecules with antidiabetic property have become one of the 
major objectives of present diabetic research. Marine environment is an exceptional reservoir of biologically active 
products. It is one of the richest sources for floral wealth and diversity [4]. Because of the unusual diversity of chemical 
structures isolated from marine organisms, there is an intense interest in screening marine natural products for their 
biomedical potential. A number of reports indicate that seaweeds are still employed in folk medicine for treatment of 
several diseases. Hence the present study was conducted to evaluate the α-amylase and α-glucosidase inhibitory activity of 
methanolic extract of S. asperum. 
 
2. Materials and Methods 
2.1 Preparation of algal material  
            The marine brown alga Spatoglossum asperum was collected from the Mandapam, South East coast of Tamilnadu. 
The sample was identified by Prof. R. Thevanathan, Professor in Botany, Presidency College, University of Madras, 
Chennai.   
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2.2 Algae extracts prepared 
The freshly collected samples were soaked and thoroughly cleaned in sea water to remove the sand and salt 
contents and then shade dried. Dried seaweed was powdered and then soaked in methanol (1:20, w/v) overnight and filtered 
to collect the methanol fraction. The residue was extracted two more times and the filtrates were combined and 
concentrated to obtain the crude extract.  
2.3 Inhibition of alpha amylase enzyme 
A starch solution of 0.1% w/v was prepared by stirring 0.1g of potato starch in 100 mL of 16 mM of sodium 
acetate buffer. The enzyme solution was prepared by mixing 27.5 mg of alpha amylase in 100 mL of distilled water. The 
colorimetric reagent was prepared by mixing sodium potassium tartarate solution and 3, 5 di nitro salicylic acid solution 96 
mM. Various concentrations of the algal extract (100 to 900 µg/mL) were added to 1 mL of starch solution and left for 10 
min. Further the reaction was initiated by the addition of the enzyme solution and allowed to react for 10 min under alkaline 
condition at 25˚C. Finally the reaction was terminated by adding 1 mL of colorimetric reagent and then incubated in a 
boiling water bath for 5 min, cooled to room temperature. The reaction mixture was then diluted by adding 10 mL of 
distilled water and absorbance was measured at 540 nm. Control represent 100% enzyme activity and were conducted in a 
similar way by replacing extract with DMSO. Similar experiment was conducted with the standard drug Acarbose. 
2.4 Inhibition of alpha glucosidase enzyme 
 The inhibitory activity was determined by incubating a solution of starch substrate           (2% w/v maltose or 
sucrose) 1 mL with 0.2 M Tris buffer pH 8.0 and various concentrations of algal extract for 5 min at 37˚C. The reaction was 
initiated by adding 1 mL of alpha glucosidase enzyme (IU/mL) to it followed by incubation for 40 min at 35˚C. Then the 
reaction was terminated by the addition of 2 mL of 6N HCl. The intensity of colour was measured at 540 nm. Control 
experiment was done by replacing the extract with DMSO and the standard drug Acarbose. Percentage of inhibition was 
calculated by using the following formulae, 
                               (OD value of control - OD value of samples)                
% of inhibition=   ------------------------------------------------------- X 100 
                                                    OD value of control 
 
3. Results 
3.1 Inhibition assay for α-amylase enzyme  
In the present study, methanolic extract of marine brown alga Spatoglossum asperum was assessed for inhibition 
of α-amylase effects on starch break down in vitro and showed potent  
α-amylase inhibitory activity. The crude methanolic extract of S. asperum at the concentration of 900 μg/mL exhibited 
95.37 ± 0.02% of inhibition (Table.1). The inhibitory activity of methanolic extracts of the brown alga was explored on the 
basis of their resulting IC50 values. There was a dose-dependent increase in the percentage inhibitory activity against α-
amylase enzyme. S. asperum inhibited the activity of α-amylase with an IC50 value of  55 µg/mL. Whereas, the positive 
control Acarbose used in this study, shows an IC50 value of  73 µg/mL. (Table.1 and Fig.1).  
 
Table 1:  Alpha amylase inhibition activity (%) of Acarbose and methanolic extract of S.asperum 
 
 
 
 
 
S. No Concentration (µg/mL) Acarbose S.asperum 
1 100 68.54 ± 0.04
 
91.31 ± 0.02 
2 300 76.19 ± 0.04
 
92.02 ± 0.01 
3 500 83.82 ± 0.03 93.46 ± 0.03 
4 700 85.99 ± 0.03 94.57 ± 0.02 
5 900 86.34 ± 0.03 95.37 ± 0.02 
6 IC50 73 µg/mL 55 µg/mL 
P – Value        0.000            0.000 
F – Value    1.303000 1.656444 
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Fig.1: Percentage of α-amylase inhibitory effects of acarbose (standard drug) and methanolic extract of S.asperum  
 
3.2 Inhibition assay for α-glucosidase enzyme  
  The methanolic extract revealed a significant inhibitory action on α-glucosidase enzyme. The crude methanolic 
extract of S. asperum at the concentration of 900 μg/mL exhibited α-glucosidase inhibitory activity of 96.75% (Table.2). S. 
asperum inhibited the activity of α-glucosidase with an IC50 value of 61 µg/mL and it was comparably higher than that of 
standard drug Acarbose (57 µg/mL) (Table.2; Fig.2). 
Table 2: Alpha-glucosidase inhibition activity (%) of Acarbose and methanolic extract of S. asperum 
S. No Concentration (µg/mL) Acarbose   S.asperum 
1 100    88.82 ± 0.02  82.75 ± 0.02 
2 300 90.25 ± 0.01 93.05 ± 0.03 
3 500 91.63 ± 0.01 95.56 ± 0.02 
4 700 93.45 ± 0.02 95.84 ± 0.03 
5 900 94.23 ± 0.03 96.75 ± 0.03 
6 IC50        57µg/mL       61 µg/mL 
P –Value             0.000 0.000 
F –Value         3.056444      1.283555 
   
 
Fig 2:   Percentage of α-glucosidase inhibitory effects of acarbose (standard drug) and methanolic extracts of S. 
asperum 
4. Discussion 
The inhibitory effects of methanolic extract of S. asperum on the α-amylase and α-glucosidase activity may be 
attributed to the presence of phytochemicals such as flavonoids, tannins and saponins. Previous studies attributed the 
medicinal property of the aqueous extract of Blighia sapida to the presence of saponins [5-6]. Newly reported group of α-
glucosidase inhibitors is the marine natural bromophenols [7-10], which are usually isolated from the marine algae.  
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Inhibition of alpha amylase enzyme activity has been noted for phlorotanins from brown algae, Ecklonia cava  and 
the IC50 value of the most effective component, decal, was calculated to be around 90 µg/mL. However phlorotannins from 
Ascophyllum have a different composition than Ecklonia [11-12] and it should be noted that the crude phlorotannin rich 
fraction from Ecklonia was considerably more effective in inhibiting alpha amylase than the most inhibitory single 
component [13].  
The extracts from some macroalgae such as Rhodomela confervoides, Gracilaria textorti, Plocamium telfairiae, 
Dictyopteris divaricata, Ulva pertusa and Enteromorpha intestinalis reported for the strong inhibitory activity of alpha-
glucosidase [14]. Similarly, the present study reports a potent inhibitory action of S. asperum against enzyme α-amylase and 
α-glucosidase enzyme when compared with Acarbose.  
Phytochemicals are natural bioactive compounds from biological sources with general benefits to human health. 
These secondary metabolites may be act as hypolipemic and hypoglycemic agents which helps in reducing blood pressure 
and regulate cholesterol levels [15].  They are considerable pharmaceutical importance since they are used as drugs for the 
treatment of several diseases known to man [16]. Marine organisms are potentially prolific sources of highly bioactive 
secondary metabolites that might represent useful leads in the development of new pharmaceutical agents [17-19].  
 
5. Conclusion 
From the discussion above, it is concluded that the results of the present study have unveil the blood glucose 
lowering activity in the marine brown alga S. asperum extract, will be further fractionated in order to search for the 
antidiabetic ingredients and also comprehensive pharmacological investigations are needed to elucidate the exact 
mechanism of the antihyperglycemic effect of S. asperum.  
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